Telix Pharmaceuticals Ltd 2022 SR
The report highlights Telix's progress in 2022 across environmental, social, and governance pillars. Key achievements include the establishment of an Environment and Environmental Sustainability Policy, an Access to Medicines Policy, and a Supplier Code of Conduct. The company implemented a reusable packaging solution for radiopharmaceutical shipments to reduce its footprint. Governance was strengthened with the appointment of a new female Non-Executive Director, bringing board female representation to 33%. Additionally, Telix advanced its clinical pipeline, notably with the positive readout of the Phase III ZIRCON studies for kidney cancer diagnosis.
Company: Telix Pharmaceuticals Ltd
Sector: Health Care
Country: Australia
Year: 2022
Type: SR
Pages: 8
Telix Pharmaceuticals Ltd
ESG And Sustainability Report
The report highlights Telix's progress in 2022 across environmental, social, and governance pillars. Key achievements include the establishment of an Environment and Environmental Sustainability Policy, an Access to Medicines Policy, and a Supplier Code of Conduct. The company implemented a reusable packaging solution for radiopharmaceutical shipments to reduce its footprint. Governance was strengthened with the appointment of a new female Non-Executive Director, bringing board female representation to 33%. Additionally, Telix advanced its clinical pipeline, notably with the positive readout of the Phase III ZIRCON studies for kidney cancer diagnosis.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Jan 1, 2022 - Dec 31, 2022
Fiscal Year
2022
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Women on Board